Collaboration on Innovations in Major Disease Diagnosis and Treatment

Philips and UMC Utrecht will seek to develop new solutions for the diagnosis, monitoring, and treatment of major disease areas.

Philips and UMC will develop collaborative research projects in medical imaging applied to brain disease, cancer, cardiovascular disease, musculoskeletal disease, and pulmonary disease. A key area of focus outlined in the MOU is image-guided oncology interventions. Philips and UMC Utrecht expect the agreement to result in new treatment methods that will ultimately lead to an improved quality of healthcare delivery.

"High-quality healthcare starts with healthcare professionals working together in teams based around their patients,” said Steve Rusckowski, CEO of Philips Healthcare and member of the Board of Management of Royal Philips. "UMC Utrecht and Philips have a long history in working together to develop groundbreaking medical technologies across a wide range of radiology, cardiology, neurology, and oncology applications. The secret of our success is our close cooperation.”

"We've signed this MOU with Philips to focus on innovation, patient care, and knowledge sharing,” said Prof. Geert Blijham, chairman of the Board of UMC Utrecht. "In particular, we'll focus on the treatments given to patients, with research principally directed towards translational research--bridging the gap between fundamental scientific research and clinical applications.”

Related Links:
Philips Healthcare
University Medical Center Utrecht